regenerative

QS11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor. Modulates ARF-GTP levels and synergizes with the Wnt/β-catenin signaling pathway to upregulate β-catenin nuclear translocation. Also reduces in vitro migration of metastatic human breast cancer cells.

NNMTi (5-Amino-1-methylquinolinium) is a substrate site-targeting, selective nicotinamide N-methyltransferase (NNMT) inhibitor (IC50 = 1.2 μM; 50 μM SAM, 100 μM NCA) that reduces 3T3-L1 lipogenesis (EC50 = 30μM) and adipocytes 1-methylnicotinamide level (EC50 = 2.3 μM) without affecting related methyltransferases & enzymes in the NAD+ salvage pathway

Smoothened (Smo) receptor agonist

NADH disodium salt hydrate belongs to natural products and is a coenzyme of oxidoreductases with oral activity, serving as an electron donor in processes such as glycolysis, the tricarboxylic acid cycle, and β-oxidation. This compound is widely used in metabolism-related experimental research.

NADH disodium salt hydrate is a coenzyme of oxidoreductase. NADH acts as a regenerative electron donor during catabolic processes including glycolysis, the citric acid cycle and beta-oxidation.

1. Pulegone ((+)-Pulegone) has cytotoxicity followed by regenerative cell proliferation is the MOA for Pulegone-induced urothelial tumors in female rats. 2. Pulegone induces a verapamil-sensitive psychostimulant effect that appears to independ on the opening of L-type calcium channels. 3. Pulegone has negative reinforcing properties and seems to possess anxiolytic-like actions unrelated to the benzodiazepine site of the γ-aminobutyric acid type A (GABAA) receptor.

Rusalatide acetate (TP508 amide acetate), a regenerative peptide, mitigates radiation-induced gastrointestinal injury by activating stem cells and preserving mucosal integrity.

CD-2394 is a novel synthetic retinoid compound. This compound's treatment reduces the number of cells in the G2M-phase, suggesting a slowdown in cell proliferation. Additionally, normal differentiation is inhibited, while keratin 13 expression is observed in CD-2394-treated samples, a phenomenon not seen in other treated skin samples. This indicates CD-2394 may induce an embryonic differentiation pathway distinct from normal or regenerative differentiation.

Collagenase (Type D, animal free) is a preparation free of animal-derived components and exhibits collagenase and secondary protease activities comparable to those of Type 1 collagenase and Type 2 collagenase. The enzymatic activity of Collagenase (Type D, animal free) exceeds that of Collagenase (Type A, animal free). These characteristics support the use of Collagenase (Type D, animal free) in tissue dissociation protocols, primary cell isolation procedures, regenerative medicine research, and cell culture applications requiring animal component-free reagents.

ZSH-2208 is a retinoic acid A analogue that inhibits tumour cell proliferation and survival through RARγ-TNFAIP3 and retinoid receptors.

LATS1/2-IN-1 is a potent and selective inhibitor of LATS1 and LATS2. In the r33P functional assay, it demonstrates strong inhibitory activity with IC50 values of 4.4 nM for LATS1 and 5.5 nM for LATS2. The NanoBRET assay determined the cellular IC50 values as 136 nM for LATS1 and 36.0 nM for LATS2. This compound reduces YAP1 phosphorylation levels in mouse liver. Additionally, LATS1/2-IN-1 shows wound healing activity in HT-1080 scratch assays and in vivo SKH1 mouse punch biopsy models. It is applicable for research into regenerative medicine-related conditions, such as wound healing.

Phenamil methanesulfonate is a potent analog of Amiloride that functions as a strong and less reversible epithelial sodium channel (ENaC) blocker with an IC50 of 400 nM, Phenamil methanesulfonate also acts as a competitive inhibitor of TRPP3 and suppressing TRPP3-mediated calcium transport with an IC50 of 140 nM in Ca2+ uptake assays. Phenamil methanesulfonate robustly activates BMP signaling to promote bone repair, supporting its use in cystic fibrosis lung disease, ion channel biology, and regenerative medicine research.

XIE18-6 is a novel INK4C inhibitor that selectively blocks the biological activity of the p18 protein, a regulator of the cell cycle. XIE18-6 promotes the ex vivo expansion of both human and murine hematopoietic stem cells, making it a valuable tool for stem cell biology and regenerative medicine research.

Resolvin conjugate in tissue regeneration 1 (RCTR1) is a specialized pro-resolving mediator (SPM) biosynthesized from docosahexaenoic acid by isolated human macrophages and apoptotic polymorphonuclear (PMN) neutrophils.1It has been found in human spleen and bone marrow.2RCTR1 is produced via lipoxygenase-mediated oxidation of DHA to 7(S)-8-epoxy-17(S)-HDHA, which is conjugated to glutathione.1,2,3RCTR1 (10 nM) increases phagocytosis ofE. colior apoptotic neutrophils in isolated human monocyte-derived macrophages.2It decreases chemotaxis induced by leukotriene B4in isolated human neutrophils when used at a concentration of 10 nM. RCTR1 (1 and 10 nM) accelerates tissue regeneration in planaria. Intraperitoneal administration of RCTR1 (100 ng/animal) shortens the inflammatory resolution period and decreases inflammatory exudate neutrophil infiltration in a mouse model ofE. coli-induced peritonitis. 1.Dalli, J., Ramon, S., Norris, P.C., et al.Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathwaysFASEB J.29(5)2120-2136(2015) 2.de la Rosa, X., Norris, P.C., Chiang, N., et al.Identification and complete stereochemical assignments of the new resolvin conjugates in tissue regeneration in human tissues that stimulate proresolving phagocyte functions and tissue regenerationAm. J. Pathol.188(4)950-966(2018) 3.Rodriguez, A.R., and Spur, B.W.First total synthesis of pro-resolving and tissue-regenerative resolvin sulfido-conjugatesTetrahedron Lett.58(16)1662-1668(2017)

Integrin Binding Peptide acetate is a synthetic peptide derived from the fibronectin protein that selectively binds integrins. Integrin Binding Peptide acetate can be employed as a functional biomolecule in the preparation of PEG-based hydrogels, providing a biologically active interface for cell adhesion, migration, and mechanotransduction studies in tissue engineering and regenerative medicine.

1. Betulonic acid (Liquidambaric acid) amide stimulated the regenerative response in hepatocytes under conditions of combined toxic exposure and promoted recovery of their qualitative and quantitative characteristics, which was accompanied by a significant decrease in the severity of liver fibrosis and the absence of cirrhotic transformation of the liver. 2. Betulonic acid derivatives have a promising cytostatic activity in vitro and could be used as potential leads for the development of new type of anti-cancer agents. 3. Betulonic acid has antiholestatic effects in mice.

β-Nicotinamide adenine dinucleotide reduced dipotassium is an orally active, reduced coenzyme that functions as a donor of ADP-ribose units in ADP-ribosylation reactions and as a precursor of cyclic ADP-ribose. It also serves as a regenerative electron donor in essential cellular energy metabolism processes, including glycolysis, β-oxidation, and the tricarboxylic acid (TCA) cycle [1].

Unasnemab (MT-3921), a humanized IgG1 monoclonal antibody, exerts its biological effects by binding to the repulsive guidance molecule A (RGMa), which in turn enhances locomotor function and promotes neuroregeneration. Unasnemab (MT-3921) demonstrates potential utility in the field of spinal cord injury research, where it provides an experimental approach to explore regenerative therapies targeting inhibitory guidance molecules.

C3bot(154-182) TFA, a C3 peptide, facilitates spinal cord injury recovery by promoting regenerative growth of descending fiber tracts. It serves as a potential therapeutic agent to support axonal protection and/or repair, alongside functional recovery following traumatic central nervous system (CNS) injury [1].

O4I4 is an OCT4-inducing compound capable of activating endogenous OCT4 and its associated signaling pathways in a variety of cell lines, with the advantage of metabolic stability.Oct4-inducing Compound 4 has shown anti-aging effects in Cryptobacterium hidradii nematodes and Drosophila, and O4I4 can be used as a substitute for exogenous OCT4 to reprogram human fibroblasts to a pluripotent state, with potential applications in regenerative medicine.

PLGA-PEG-PLGA (LA:GA 3:1) (20% solution) is a biodegradable and thermosensitive hydrogel that undergoes phase transition at specific temperatures. PLGA-PEG-PLGA (hydrogel) (LA:GA 3:1) (20% solution) is widely utilized in delivery system development, tissue engineering, wound dressing research, and biosensor applications. The physicochemical characteristics of PLGA-PEG-PLGA (hydrogel) (LA:GA 3:1) (20% solution) support extensive investigation in biomaterials science and regenerative medicine research.

Hyaluronic acid methacryloyl (MW 300000) (HAMA (MW 300000)) is a natural extracellular matrix (ECM) with anti-inflammatory properties that promotes cell adhesion and proliferation. This compound is extensively used in tissue engineering and regenerative medicine. Upon exposure to ultraviolet light, Hyaluronic acid methacryloyl (MW 300000) (HAMA (MW 300000)) quickly forms a hydrogel.

Pulegone (Standard) is a reference standard for research and analysis in studies involving Pulegone. 1. Pulegone ((+)-Pulegone) has cytotoxicity followed by regenerative cell proliferation is the MOA for Pulegone-induced urothelial tumors in female rats. 2. Pulegone induces a verapamil-sensitive psychostimulant effect that appears to independ on the opening of L-type calcium channels. 3. Pulegone has negative reinforcing properties and seems to possess anxiolytic-like actions unrelated to the benzodiazepine site of the γ-aminobutyric acid type A (GABAA) receptor.

Betulonic acid (Standard) is a reference standard for research and analysis in studies involving Betulonic acid. 1. Betulonic acid (Liquidambaric acid) amide stimulated the regenerative response in hepatocytes under conditions of combined toxic exposure and promoted recovery of their qualitative and quantitative characteristics, which was accompanied by a significant decrease in the severity of liver fibrosis and the absence of cirrhotic transformation of the liver. 2. Betulonic acid derivatives have a promising cytostatic activity in vitro and could be used as potential leads for the development of new type of anti-cancer agents. 3. Betulonic acid has antiholestatic effects in mice.